HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yilong Wang Selected Research

Therapeutics

2/2024One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA Trial.
2/2024Differential effect of ticagrelor versus clopidogrel by homocysteine levels on risk of recurrent stroke: a post hoc analysis of the CHANCE-2 trial.
1/2024Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial.
1/2024Effects of remnant cholesterol on the efficacy of genotype-guided dual antiplatelet in CYP2C19 loss-of -function carriers with minor stroke or transient ischaemic attack: a post-hoc analysis of the CHANCE-2 trial.
12/2023Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke.
10/2023Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack.
5/2023Recombinant measles virus vaccine rMV-Hu191 exerts an oncolytic effect on esophageal squamous cell carcinoma via caspase-3/GSDME-mediated pyroptosis.
4/2023Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct.
4/2023AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells.
1/2023Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke: A Randomized Clinical Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yilong Wang Research Topics

Disease

213Stroke (Strokes)
02/2024 - 01/2006
167Ischemic Stroke
03/2024 - 01/2006
67Transient Ischemic Attack
02/2024 - 05/2008
31Hemorrhage
02/2024 - 07/2013
20Pathologic Constriction (Stenosis)
01/2024 - 01/2012
19Diabetes Mellitus
12/2022 - 05/2008
16Atherosclerosis
12/2023 - 01/2012
16Neoplasms (Cancer)
05/2023 - 05/2008
15Atrial Fibrillation
03/2023 - 01/2013
11Hypertension (High Blood Pressure)
12/2022 - 05/2009
11Cerebral Hemorrhage
08/2021 - 05/2008
10Insulin Resistance
02/2024 - 01/2017
10Cognitive Dysfunction
01/2024 - 09/2012
9Inflammation (Inflammations)
04/2024 - 01/2019
7Infarction (Infarctions)
05/2023 - 03/2012
7Hyperglycemia
01/2022 - 11/2017
5Wounds and Injuries (Trauma)
04/2024 - 01/2021
5Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2023 - 03/2015
5Prediabetic State (Prediabetes)
01/2023 - 03/2012
5Cardiovascular Diseases (Cardiovascular Disease)
12/2022 - 01/2017
5Embolic Stroke
12/2020 - 01/2013
4Cerebral Infarction
04/2023 - 03/2019
4Cerebrovascular Disorders (Cerebrovascular Occlusion)
02/2023 - 01/2020
4Cerebral Small Vessel Diseases
10/2022 - 01/2014
4COVID-19
02/2022 - 10/2020
4Hematoma
01/2022 - 12/2011
4Heart Failure
05/2018 - 05/2013
4Leukoaraiosis
11/2014 - 05/2009
3Thrombosis (Thrombus)
10/2023 - 01/2014
3Obesity
10/2023 - 10/2017
3Coronary Disease (Coronary Heart Disease)
01/2023 - 10/2011
3Alzheimer Disease (Alzheimer's Disease)
01/2023 - 09/2012
3Glucose Intolerance
08/2022 - 05/2010
3Deglutition Disorders (Dysphagia)
01/2022 - 05/2013
3Chronic Renal Insufficiency
12/2018 - 01/2014
3Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2017 - 06/2011
2Lung Neoplasms (Lung Cancer)
04/2024 - 02/2013
2Acute Kidney Injury (Acute Renal Failure)
04/2024 - 01/2023
2Brain Ischemia (Cerebral Ischemia)
12/2023 - 08/2013
2Heart Diseases (Heart Disease)
10/2023 - 08/2013
2Type 2 Diabetes Mellitus (MODY)
10/2023 - 12/2022
2Measles
05/2023 - 01/2018

Drug/Important Bio-Agent (IBA)

66Clopidogrel (Plavix)FDA Link
02/2024 - 07/2013
59Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2024 - 01/2006
39Glucose (Dextrose)FDA LinkGeneric
02/2024 - 05/2010
25Cytochrome P-450 CYP2C19IBA
02/2024 - 07/2016
24Biomarkers (Surrogate Marker)IBA
04/2024 - 03/2015
22TicagrelorIBA
02/2024 - 01/2017
22Tissue Plasminogen Activator (Alteplase)FDA Link
01/2024 - 02/2009
16C-Reactive ProteinIBA
09/2023 - 01/2013
12Antihypertensive Agents (Antihypertensives)IBA
10/2023 - 05/2008
12danaparoid (Orgaran)FDA Link
01/2023 - 07/2010
11Triglycerides (Triacylglycerol)IBA
01/2023 - 11/2015
11Blood Glucose (Blood Sugar)IBA
01/2022 - 01/2012
9Hemoglobins (Hemoglobin)IBA
01/2024 - 01/2016
9oxidized low density lipoproteinIBA
01/2021 - 06/2011
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2023 - 01/2014
7AlbuminsIBA
04/2024 - 03/2015
7CholesterolIBA
01/2024 - 06/2011
7Indicators and Reagents (Reagents)IBA
01/2024 - 01/2014
7LipidsIBA
07/2023 - 12/2016
7Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
05/2023 - 10/2015
6MicroRNAs (MicroRNA)IBA
03/2024 - 01/2017
5HomocysteineIBA
02/2024 - 07/2010
5Proteins (Proteins, Gene)FDA Link
10/2022 - 12/2018
5Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2021 - 01/2013
4TenecteplaseFDA Link
01/2024 - 01/2022
4Therapeutic UsesIBA
04/2023 - 01/2021
4LDL Lipoproteins (beta Lipoproteins)IBA
01/2023 - 05/2009
4AnticoagulantsIBA
01/2021 - 05/2008
3Fibrinogen (Factor I)FDA Link
04/2024 - 07/2023
3CytokinesIBA
02/2024 - 08/2017
3ORALIT (ORS)IBA
10/2023 - 01/2019
3VaccinesIBA
05/2023 - 01/2018
3EnzymesIBA
01/2023 - 10/2019
3Lipoprotein(a)IBA
07/2022 - 12/2019
31-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
06/2022 - 11/2015
3HydrogelsIBA
03/2022 - 01/2021
3HDL CholesterolIBA
01/2022 - 01/2021
3Insulin (Novolin)FDA Link
01/2022 - 05/2014
3LDL CholesterolIBA
01/2021 - 10/2015
3EdaravoneIBA
01/2021 - 10/2018
3HDL LipoproteinsIBA
01/2021 - 12/2017
3RivaroxabanIBA
06/2018 - 09/2016
3Warfarin (Coumadin)FDA LinkGeneric
02/2016 - 05/2014
2RNA (Ribonucleic Acid)IBA
04/2024 - 06/2022
2coactivator-associated arginine methyltransferase 1IBA
04/2024 - 10/2022
2Cisplatin (Platino)FDA LinkGeneric
04/2024 - 01/2023
24- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA
12/2023 - 01/2015
2Folic Acid (Vitamin M)FDA LinkGeneric
10/2023 - 07/2013
2Heparin (Liquaemin)FDA LinkGeneric
10/2023 - 10/2020
2Tirofiban (Aggrastat)FDA Link
05/2023 - 01/2021

Therapy/Procedure

93Therapeutics
02/2024 - 02/2009
26Secondary Prevention
02/2024 - 01/2006
15Thrombectomy
12/2023 - 06/2016
7Stents
10/2023 - 10/2015
6Length of Stay
01/2017 - 12/2011
3Punctures
01/2021 - 10/2017
3Thrombolytic Therapy
12/2020 - 06/2011
2Precision Medicine
07/2023 - 04/2018